What is the Y-tunnus number of Essilor Oy?

Essilor Oy is registered with PRH / YTJ under Y-tunnus 0581801-2.

What is the revenue of Essilor Oy?

Essilor Oy reported revenue of EUR 18,5M in 2024.

Timo Antero Tuokko is Audit of Essilor Oy, in role since 2015.

Bernhard Nüsser chairs the board of Essilor Oy, in role since 2016.

Essilor Oy's registered address is Lämmittäjänkatu 2.

OYActive

Y-tunnus 0581801-2Lämmittäjänkatu 2, 00810 HelsinkiWholesale of pharmaceutical and medical goods · NACE 4646Est. 1985— employeeswww.essilor.fi

Actively employed in the business

Name	Role	Member since
Former (7)
TA Timo Antero Tuokko Audit	Audit	2015 – 2023
JJ Jyrki Juhani Immonen Confidential Clerk	Confidential Clerk	2019 – 2023
NA Niina Anna Marita Miettinen Confidential Clerk	Confidential Clerk	2018 – 2021
TJ Timothy James Precious Chief Executive Officer	Chief Executive Officer	2016 – 2019
Sd Sebastiaan de Jong Chief Executive Officer	Chief Executive Officer	2019 – 2020
JE Johanna Eeva-Maria Guillou Confidential Clerk	Confidential Clerk	2023 – 2026
PJ Pasi Juhani Kostiainen Confidential Clerk	Confidential Clerk	2018 – 2019

Non-executive oversight

Name	Role	Member since
Current (3)
CP Carl Pontus Gynning	Board of Directors	2026
LR Leonardo Rosato	Board of Directors	2023
CÅ Carl Åke Fredrik Jönsson	Chairperson	2024
Former (11)
JM Johanna Maila Aulikki Haltia-Tapio	Board of Directors	2016 – 2022
BN Bernhard Nüsser	Chairperson	2016 – 2020
MM Meri Mirjami Lahtela	Board of Directors	2022 – 2023
FF Franco Ferrante	Chairperson	2022 – 2024
GR Giona Riccetti	Board of Directors	2023 – 2026
CR Casper Randløv Rasmussen	Board of Directors	2020 – 2021
RB Roberto Barberio	Board of Directors	2023 – 2023
OM Olivier Marie Alain Chupin	Chairperson	2020 – 2021
JM James Michael Smith	Board of Directors	2021 – 2023
PH Prûne Hélène Marre	Chairperson	2021 – 2022
AH Anne Hélène Borgne	Board of Directors	2016 – 2019

As of last annual report

No shareholder data available.

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.